中财网 中财网股票行情
泽璟制药-U(688266)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)16764.2053295.4438411.7224069.6710824.44
营业收入(万元)16764.2053295.4438411.7224069.6710824.44
营业总成本(万元)22489.1773065.6951277.8333353.0515951.20
营业成本(万元)1946.783699.142702.451749.60714.92
净利润(万元)-2812.33-14635.54-7373.43-6625.12-3941.94
归属于母公司的净利润(万元)-2826.22-13783.08-9790.30-6653.61-3949.94
营业利润(万元)-3001.70-15504.32-11254.81-7943.60-4562.43
利润总额(万元)-3031.70-15504.78-11260.27-7949.34-4562.38
少数股东损益(万元)-105.11-1246.75-1174.36-1099.16-513.14
基本每股收益(元)-0.11(元)-0.52(元)-0.37(元)-0.25(元)-0.15(元)
稀释每股收益(元)-0.11(元)-0.52(元)-0.37(元)-0.25(元)-0.15(元)
非经常性损益(万元)2181.873332.95665.38583.52300.35
扣除非经常性损益后净利润(万元)-5008.10-17116.03-10455.68-7237.12-4250.29
总资产(万元)291782.39300461.43296714.79309966.30310474.80
总负债(万元)169409.40175201.37166434.19153129.71150403.60
归属于母公司股东权益合计(万元)122601.30125385.79130338.75156704.45159369.36
股东权益合计(万元)122372.99125260.05130280.60156836.60160071.20
实收资本(股本)(万元)26470.8226470.8226470.8226470.8226470.82
资本公积(万元)312064.51312036.66309727.51335344.90335326.63
未分配利润(万元)-214500.47-211674.25-207681.47-204544.78-201841.11
经营活动产生的现金流量净额(万元)-625.323820.456664.7111255.318902.39
经营活动现金流入小计(万元)21678.1487282.9070286.4054016.2131002.47
经营活动现金流出小计(万元)22303.4683462.4563621.7042760.9022100.09
投资活动产生的现金流量净额(万元)-2663.07-184510.14845.533558.78-31590.15
投资活动现金流入小计(万元)717.74121708.86101686.5879926.4511732.48
投资活动现金流出小计(万元)3380.81306219.00100841.0676367.6743322.63
筹资活动产生的现金流量净额(万元)-3179.61-5131.64-7812.564436.489461.21
筹资活动现金流入小计(万元)14132.19128861.8579800.0052800.0034900.00
筹资活动现金流出小计(万元)17311.80133993.4987612.5648363.5225438.79
期末现金及现金等价物余额(万元)15257.6321726.55207421.72227031.99194552.25
最后修改日期2025-04-212025-04-212024-10-292024-08-262024-04-20
↑返回页顶↑

转至泽璟制药-U（688266）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。